Bioavailability and Bioequivalence of Two Enteric-Coated Formulations of Omeprazole in Fasting and Fed Conditions

@article{VazdaSilva2005BioavailabilityAB,
  title={Bioavailability and Bioequivalence of Two Enteric-Coated Formulations of Omeprazole in Fasting and Fed Conditions},
  author={M. Vaz-da-Silva and A. Loureiro and T. Nunes and J. Maia and Susana Tavares and A. Falc{\~a}o and Pedro Silveira and L. Almeida and P. Soares-da-Silva},
  journal={Clinical Drug Investigation},
  year={2005},
  volume={25},
  pages={391-399}
}
AbstractObjective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated formulations in healthy volunteers. Material and methods: Open label, single-centre study consisting of two consecutive randomised, two-way crossover trials (a fasting trial and a fed trial). Each trial consisted of two 7-day treatment periods in which subjects received one daily dose of the test (Ompranyt®) or reference (Mopral… Expand
31 Citations
Bioequivalence of Omeprazole Delayed-Release Capsules in HealthyFilipino Subjects
  • 2
  • PDF
Biliary Excretion-Mediated Food Effects and Prediction.
Food, physiology and drug delivery.
  • 84
...
1
2
3
4
...

References

SHOWING 1-10 OF 15 REFERENCES
Bioequivalence study of two capsule formulations of omeprazole.
  • 6
Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
  • 10
Bioequivalence evaluation of two omeprazole enteric-coated formulations in humans.
  • 24
Clinical Pharmacology of Omeprazole
  • C. Howden
  • Medicine
  • Clinical pharmacokinetics
  • 1991
  • 129
Statistical approaches to establishing bioequivalence
  • 131
Reference tables for the intrasubject coefficient of variation in bioequivalence studies.
  • 33
...
1
2
...